Cargando…
Intravenous Ferric Chloride Hexahydrate Supplementation Induced Endothelial Dysfunction and Increased Cardiovascular Risk among Hemodialysis Patients
BACKGROUND: The association between intravenous (IV) iron administration and outcomes in hemodialysis (HD) patients is still debated. Therefore, this study was aimed to assess the relationship between the IV administration of ferric chloride hexahydrate (Atofen®) and cardiovascular (CV) outcome and...
Autores principales: | Kuo, Ko-Lin, Hung, Szu-Chun, Lin, Yao-Ping, Tang, Ching-Fang, Lee, Tzong-Shyuan, Lin, Chih-Pei, Tarng, Der-Cherng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515606/ https://www.ncbi.nlm.nih.gov/pubmed/23227165 http://dx.doi.org/10.1371/journal.pone.0050295 |
Ejemplares similares
-
Correction: Intravenous Ferric Chloride Hexahydrate Supplementation Induced Endothelial Dysfunction and Increased Cardiovascular Risk among Hemodialysis Patients
por: Kuo, Ko-Lin, et al.
Publicado: (2013) -
Safety and efficacy of ferric citrate in phosphate reduction and iron supplementation in patients with chronic kidney disease
por: Wu, Mei-Yi, et al.
Publicado: (2017) -
Genetic Deletion of Soluble Epoxide Hydrolase Attenuates Inflammation and Fibrosis in Experimental Obstructive Nephropathy
por: Chiang, Chin-Wei, et al.
Publicado: (2015) -
Impact of Indoxyl Sulfate on Progenitor Cell-Related Neovascularization of Peripheral Arterial Disease and Post-Angioplasty Thrombosis of Dialysis Vascular Access
por: Wu, Chih-Cheng, et al.
Publicado: (2017) -
Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease
por: Hung, Szu‐Chun, et al.
Publicado: (2017)